ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "polymorphism and systemic sclerosis"

  • Abstract Number: 2997 • 2015 ACR/ARHP Annual Meeting

    A Genome-Wide Association Study of a Hispanic Systemic Sclerosis Cohort

    Lara Bossini-Castillo1, Enrique Raya2, John D. Reveille3, Shervin Assassi4, Olga Y Gorlova5, Dinesh Khanna6, Daniel E. Furst7, Suzanne Kafaja8, Robert W. Simms9, Robert Lafyatis9, Tracy M. Frech10, Virginia D. Steen11, Barri J. Fessler12, Jerry A. Molitor13, Marta Alarcón-Riquelme14,15, Javier Martín16 and Maureen D Mayes4, 1Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS Granada, Granada, Spain, 2Rheumatology, Hospital Clínico San Cecilio, Granada, Spain, 3Internal Medicine/Rheumatology, University of Texas Medical School at Houston, Houston, TX, 4Rheumatology, University of Texas Medical School at Houston, Houston, TX, 5Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, 6Division of Rheumatology, University of Michigan, Ann Arbor, MI, 7Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 8Rheumatology, University of California Los Angeles, Los Angeles, CA, 9Rheumatology, Boston University School of Medicine, Boston, MA, 10Div of Rheumatology, University of Utah, Salt Lake City, UT, 11Department of Rheumatology, Georgetown University Medical Center, Washington, DC, 12Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 13Rheumatology, University of Minnesota, Minneapolis, MN, 14Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma, OK, 15Centre for Genomics and Oncological Research (GENYO), Pfizer–University of Granada–Junta de Andalucia, Parque Tecnológico de la Salud (PTS), Granada, Spain, 16Instituto de Parasitología y Biomedicina López- Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain

    Background/Purpose: Genome-wide association studies (GWASs) have resulted in the identification of several genetic loci involved in systemic sclerosis (SSc) susceptibility. However, GWASs are normally focused…
  • Abstract Number: 1130 • 2014 ACR/ARHP Annual Meeting

    IRF8 Gene Contributes to Disease Susceptibility and Interacts with NF-KB By Modulating Interferon Signature in Patients with Systemic Sclerosis

    Maria Arismendi1,2, Matthieu Giraud1, Nadira Ruzehaji1, Philippe Dieude3, Eugénie Koumakis4, Barbara Ruiz5, Paolo Airo6, Daniele Cusi7, Marco Matucci-Cerinic8, Erika Salvi9, Giovanna Cuomo10, Eric Hachulla11, Elizabeth Diot12, Paola Caramaschi13, Valeria Riccieri14, Jerome Avouac15, Cristiane Kayser16 and Yannick Allanore17, 1INSERM U1016, Paris Descartes University, Paris, France, 2Department of Rheumatology, Federal University of São Paulo, São Paulo, Brazil, 3Rhumatologie, Hopital Bichat Claude Bernard, Paris, France, 4Rheumatology A department, Cochin Hospital, Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France, 5Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France, 6Rheumatology and Clinical Immunology, Spedali Civili, AO Spedali Civili, Brescia, Italy, 7Department of Medicine, Surgery and Dentistry San Paolo & Genomics and Bioinformatics Platform, Fondazione Filarete, University of Milano, Milano, Italy, 8RAID working group for EULAR, Zurich, Switzerland, 9Department of Medicine, Surgery and Dentistry San Paolo & Genomics and Bioinformatics Platform, Fondazione Filarete, University of Milano, Milan, Italy, 10Department of Internal and Experimental Medicine, Second University of Naples, Naples, Italy, 11Faculté de Médecine Henri Warembourg, Université Lille Nord de France, Lille, France, 12Department of Internal Medicine, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours, Tours, France, Tours, France, 13Rheumatology Unit, Department of Medicine, Verona, Italy, 14Department of Internal Medicine and Medical Specialities, University Sapienza, Rome, Italy, 15Cochin Hospital, Paris, France, 16Rheumatology Division, Universidade Federal de São Paulo, São Paulo - SP, Brazil, 17Paris Descartes University, Rheumatology A Department and INSERM U1016, Cochin Hospital, Paris, France

    Background/Purpose . Systemic Sclerosis (SSc) is a polygenic autoimmune disease (AID) characterized by fibroblast dysregulation. It shares some genetic bases with other AIDs, as evidenced…
  • Abstract Number: 745 • 2014 ACR/ARHP Annual Meeting

    Genetic Susceptibility Loci of Idiopathic Interstitial Pneumonitis Do Not Represent Risk for Systemic Sclerosis

    Minghua Wu1, Shervin Assassi1, Gloria Salazar1, Olga Y Gorlova2, Wei V Chen3, Julio Charles4, Fredrick M. Wigley5, Laura K. Hummers5, Ami A. Shah5, Monique Hinchcliff6, Dinesh Khanna7, Elena Schiopu8, Kristine Phillips7, Daniel E. Furst9, Virginia D. Steen10, Murray Baron11, Marie Hudson11, Xiaodong Zhou1, Janet E. Pope12, Niall Jones13, Peter Docherty14, Nader A. Khalidi15, David B. Robinson16, Robert W. Simms17, Richard Silver18, Tracy Frech19, Barri J. Fessler20, Marvin J. Fritzler21, Jerry A. Molitor22, Barbara M. Segal22, Javier Martín23, John Varga24 and Maureen D Mayes1, 1Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 2Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, 3Geisel School of Medicine at Dartmouth, Hanover, NH, 4Internal Medicine/Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 5Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 6Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 7Division of Rheumatology, University of Michigan, Ann Arbor, MI, 8Rheumatology, University of Michigan, Ann Arbor, MI, 9University of California, Los Angeles, Department of Medicine, Los Angeles, CA, 10Department of Rheumatology, Georgetown University Medical Center, Washington, DC, 11Division of Rheumatology, McGill University, Montreal, QC, Canada, 12Medicine/Rheumatology, St. Joseph's Health Care, University of Western Ontario, London, ON, Canada, 13Division of Rheumatology, University of Alberta, Edmonton, AB, Canada, 14Internal Medicine, The Moncton Hospital, Moncton, NB, Canada, 15Division of Rheumatology, St. Joseph’s Hospital, McMaster University, Hamilton, ON, Canada, 16Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, 17Rheumatology, Boston University School of Medicine, Boston, MA, 18Division of Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, 19Div of Rheumatology, University of Utah, Salt Lake City, UT, 20Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 21Mitogen Advanced Diagnostics Laboratory, Faculty of Medicine, University of Calgary, Calgary, AB, Canada, 22Rheumatology, University of Minnesota, Minneapolis, MN, 23Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain, 24Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Systemic sclerosis (SSc) related interstitial lung disease (ILD) has phenotypic similarities to idiopathic interstitial pneumonia (IIP). The objective of this study was to assess…
  • Abstract Number: 86 • 2014 ACR/ARHP Annual Meeting

    Association of Leukocyte Immunoglobulin-like Receptor A3 (LILRA3) with Systemic Sclerosis

    Yuki Hachiya1, Aya Kawasaki1, Takashi Matsushita2, Hiroshi Furukawa3, Shouhei Nagaoka4, Kota Shimada5, Shoji Sugii5, Takayuki Sumida6, Shigeto Tohma3, Minoru Hasegawa7, Manabu Fujimoto8, Shinichi Sato9, Kazuhiko Takehara10 and Naoyuki Tsuchiya1, 1Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Deramtology, Kanazawa University, Kanazawa, Japan, 3Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan, 4Department of Rheumatology, Yokohama Minami Kyousai Hospital, Yokohama, Japan, 5Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 6Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 7Dermatology, University of Fukui, Yoshida-gun, Fukui, Japan, 8Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 9Department of Dermatology, The University of Tokyo, Tokyo, Japan, 10Dermatology, Kanazawa University, Kanazawa, Japan

    Background/Purpose: The leukocyte immunoglobulin-like receptors (LILRs) are a gene family located in leukocyte receptor complex at 19q13.4. LILRs are expressed mainly in immune cells as…
  • Abstract Number: 701 • 2012 ACR/ARHP Annual Meeting

    Vascular Differences Associated to Genetic Polymorphisms of Endothelial Nitric Oxide Synthase in Mexican Patients with Systemic Sclerosis. A Preliminary Report

    Maria Pilar Cruz-Dominguez1, Maria Angeles Martinez-Godinez2, Angel Miliar-Garcia2, Daniel Hector Montes-Cortes3, Olga Vera-Lastra4, Luis J. Jara-Quezada5 and Anabel Reyes-Salazar6, 1Division of Research, Hospital de Especialidades Centro Medico Nacional La Raza., Mexico, DF, Mexico, 2Postgraduate Studies and Research Section, Escuela Superior de Medicina. IPN,, Mexico, D.F., Mexico, 3Investigación, Hospital General CMN La Raza, IMSS, Mexico DF, Mexico, 4Internal Medicine, MD, Mexico City, Mexico, 5Direction of Education and Research, Hospital de Especialidades Centro Médico La Raza, IMSS, Mexico City, Mexico, 6Angiology, Hospital de especialidades Centro Medico National “La Raza”, IMSS, Mexico, D.F., Mexico

    Background/Purpose: Vascular dysfunction usually is observed before clinically detectable fibrosis of systemic sclerosis (SSc). The eNOS catalyses the synthesis of nitric oxide (NO), which maintains…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology